Long-term prognosis of multiple sclerosis in Australia

J Neurol Sci. 2007 May 15;256(1-2):35-8. doi: 10.1016/j.jns.2007.02.004. Epub 2007 Mar 21.

Abstract

Long-term survival and progression of disability in multiple sclerosis have not been studied previously in Australia. We report the findings in a cohort of 159 patients from Newcastle. Median survival time from onset of symptoms to death was 42 years. When expected survival rates are compared with those of the Australian population, there is approximately a 10% reduction in survival time in multiple sclerosis patients, after 20 years or more from disease onset. The expected time to reach DSS 3 and DSS 6 was 7 years and 27 years respectively. Survival time of multiple sclerosis patients and rate of progression of the disease are similar in the Northern and Southern Hemispheres.

MeSH terms

  • Adult
  • Australia / epidemiology
  • Disability Evaluation
  • Disease Progression
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Multiple Sclerosis* / epidemiology
  • Multiple Sclerosis* / mortality
  • Multiple Sclerosis* / physiopathology
  • Prognosis
  • Survival Analysis